{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:35:21Z","timestamp":1783478121493,"version":"3.55.0"},"reference-count":19,"publisher":"The Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,1]]},"DOI":"10.1210\/jc.2018-01151","type":"journal-article","created":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T14:02:06Z","timestamp":1537797726000},"page":"550-556","source":"Crossref","is-referenced-by-count":88,"title":["Immune Checkpoint Inhibitor-Induced Hypoparathyroidism Associated With Calcium-Sensing Receptor-Activating Autoantibodies"],"prefix":"10.1210","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2323-7206","authenticated-orcid":false,"given":"Paramarajan","family":"Piranavan","sequence":"first","affiliation":[{"name":"Department of Medicine, Saint Vincent Hospital, Worcester, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Medicine, Saint Vincent Hospital, Worcester, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Brown","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Diabetes and Hypertension, Brigham and Women\u2019s Hospital and Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E Helen","family":"Kemp","sequence":"additional","affiliation":[{"name":"Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitin","family":"Trivedi","sequence":"additional","affiliation":[{"name":"Division of Endocrinology, Saint Vincent Hospital, Worcester, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,9,24]]},"reference":[{"key":"key\n\t\t\t\t2019010405285012600_B1","first-page":"49","article-title":"Current diagnosis and management of immune related adverse events (irAEs) induced by immune checkpoint inhibitor therapy","volume":"8","author":"Kumar","year":"2017","journal-title":"Front Pharmacol"},{"issue":"2","key":"key\n\t\t\t\t2019010405285012600_B2","first-page":"158","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019010405285012600_B3","first-page":"70","article-title":"Endocrine-related adverse events associated with immune checkpoint blockade and expert insights on their management","volume":"58","author":"Sznol","year":"2017","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"key\n\t\t\t\t2019010405285012600_B4","first-page":"121","article-title":"Use of immune checkpoint inhibitors in the treatment of patients with cancer and preexisting autoimmune disease: A systematic review","volume":"168","author":"Abdel-Wahab","year":"2018","journal-title":"Ann Intern Med"},{"issue":"2","key":"key\n\t\t\t\t2019010405285012600_B5","first-page":"173","article-title":"Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: A systematic review and meta-analysis","volume":"4","author":"Barroso-Sousa","year":"2018","journal-title":"JAMA Oncol"},{"issue":"7","key":"key\n\t\t\t\t2019010405285012600_B6","first-page":"1039.e5","article-title":"Acute symptomatic hypocalcemia from immune checkpoint therapy-induced hypoparathyroidism","volume":"35","author":"Win","year":"2017","journal-title":"Am J Emerg Med"},{"issue":"6455","key":"key\n\t\t\t\t2019010405285012600_B7","first-page":"575","article-title":"Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid","volume":"366","author":"Brown","year":"1993","journal-title":"Nature"},{"issue":"21","key":"key\n\t\t\t\t2019010405285012600_B8","first-page":"8366","article-title":"Antibodies cytotoxic to bovine parathyroid cells in autoimmune hypoparathyroidism","volume":"83","author":"Brandi","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5","key":"key\n\t\t\t\t2019010405285012600_B9","first-page":"475","article-title":"Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells","volume":"1","author":"Posillico","year":"1986","journal-title":"J Bone Miner Res"},{"issue":"2","key":"key\n\t\t\t\t2019010405285012600_B10","first-page":"548","article-title":"Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism","volume":"89","author":"Kifor","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"key\n\t\t\t\t2019010405285012600_B11","first-page":"4749","article-title":"Activating autoantibodies against the calcium-sensing receptor detected in two patients with autoimmune polyendocrine syndrome type 1","volume":"94","author":"Kemp","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key\n\t\t\t\t2019010405285012600_B12","first-page":"2107","article-title":"The calcium-sensing receptor is a target of autoantibodies in patients with autoimmune polyendocrine syndrome type 1","volume":"92","author":"Gavalas","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"key\n\t\t\t\t2019010405285012600_B13","first-page":"1018","article-title":"Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen","volume":"358","author":"Alimohammadi","year":"2008","journal-title":"N Engl J Med"},{"issue":"7","key":"key\n\t\t\t\t2019010405285012600_B14","first-page":"e289","article-title":"Anti-interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1","volume":"3","author":"Meager","year":"2006","journal-title":"PLoS Med"},{"issue":"2","key":"key\n\t\t\t\t2019010405285012600_B15","first-page":"291","article-title":"Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I","volume":"207","author":"Puel","year":"2010","journal-title":"J Exp Med"},{"issue":"2","key":"key\n\t\t\t\t2019010405285012600_B16","first-page":"437","article-title":"Anti-parathyroid and anti-calcium sensing receptor antibodies in autoimmune hypoparathyroidism","volume":"38","author":"Brown","year":"2009","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"12","key":"key\n\t\t\t\t2019010405285012600_B17","first-page":"1132","article-title":"Autoimmune polyendocrine syndromes","volume":"378","author":"Husebye","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"key\n\t\t\t\t2019010405285012600_B18","first-page":"2317","article-title":"Hypoparathyroidism in the adult: epidemiology, diagnosis, pathophysiology, target-organ involvement, treatment, and challenges for future research","volume":"26","author":"Bilezikian","year":"2011","journal-title":"J Bone Miner Res"},{"issue":"2","key":"key\n\t\t\t\t2019010405285012600_B19","first-page":"133","article-title":"Immune checkpoint inhibitors: new strategies to checkmate cancer","volume":"191","author":"Wilson","year":"2018","journal-title":"Clin Exp Immunol"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/2\/550\/27378256\/jc.2018-01151.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,4]],"date-time":"2019-01-04T05:29:40Z","timestamp":1546579780000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/2\/550\/5105937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,24]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2018,9,24]]},"published-print":{"date-parts":[[2019,2,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2018-01151","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2]]},"published":{"date-parts":[[2018,9,24]]}}}